1[1]Brezis M,Rosen S.Hypoxia of the renal medulla-its implications for disease[J].N Engl J Med,1995,332(10):647-655.
2[2]Mason RP.Non-invasive assessment of kidney oxygenation:a role for BOLD MRI[J].Kidney Int,2006,70(1):10-11.
3[3]Prasad PV.Evaluation of intra renal oxygenation by BOLD MRI[J].Nephron Clin Pract,2006,103(2):c58-c65.
4[4]Kone BC.A'BOLD' new approach to renal oxygen economy[J].Circulation,1996,94(12):3067-3068.
5[5]Prasad PV.Functional MRI of the kidney:tools for translational studies of pathophysiology of renal disease[J].Am J Physiol Renal Physiol,2006,290(5):F958-F574.
6[6]Prasad PV,Edelman RR,Epstein FH.Noninvasive evaluation of intrarenal oxygenation with BOLD MRI[J].Circulation,1996,94(12):3271-3275.
7[7]Dunn JF,Swartz HM.Blood oxygenation heterogeneity of hypoxic tissues monitored using bold MR imaging[J].Adv Exp Med Biol,1997,428:645-650.
8[8]Prasad PV,Chen Q,Goldfarb JW,et al.Breath-hold R2*mapping with a multiple gradient-recalled echo sequence:application to the evaluation of intrarenal oxygenation[J].J Magn Reson Imaging,1997,7(6):1163-1165.
9[9]Prasad PV,Epstein FH.Changes in renal medullary pO2 during water diuresis as evaluated by blood oxygenation level-dependent magnetic resonance imaging:effects of aging and cyclooxygenase inhibition[J].Kidney Int,1999,55(1):294-298.
10[10]Zuo CS,Rofsky NM,Mahallati H,et al.Visualization and quantification of renal R2 * changes during water diuresis[J].J Magn Reson Imaging,2003,17(6):676-682.
3Efremidis SC, Hytiroglou P. The muhistep process of hepatocarcino- genesis in cirrhosis with imaging correlation[J]. Eur Radiol, 2002, 12(4): 753-764.
4Kudo M. Muhistep human hepatoearcinogenesis: correlation of imaging with pathology[J]. J Gastroenterol, 2009, 44 Suppl 19: Sl12-118.
5Buadu LD, Murakami J, Murayama S, et al. Patterns of peripheral enhancement in breast masses : correlation of findings on contrast medium enhanced Mill with histologie features and tumor angio- genesis[J]. J Comput Assist Tomogr, 1997, 21(3 ) : 421-430.
6Wang B, Gao ZQ, Yan X. Correlative study of angiogenesis and dy- namic contrast-enhanced magnetic resonance imaging features of hepatocellular carcinoma[J]. Acta Radiol, 2005, 46(4) : 353-358.
7Hsu CY, Shen YC, Yu CW, et al. Dynamic contrast-enhanced mag- netic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil[J]. J Hepatol, 2011, 55(4) : 858-865.
8Bachmann R, Kreft B, Dombrowski F, et al. Enhanced tumor detec- tion in the presence of liver cirrhosis: experimental study on the diagnostic value of a superparamagnetic iron oxide MR imaging contrast agent ( NSR 0430) [J]. J Magn Reson Imaging, 1999, 9 ( 2 ) : 251-256.
9Paley MR, Mergo PJ, Torres GM, et al. Characterization of focal hepatic lesions with ferumoxides-enhanced T2-weighted MR imag- ing[J]. AJR Am J Roentgenol, 2000, 175( 1 ) : 159-163.
10Stadlbauer A, Nimsky C, Gruber S, et al. Changes in fiber integrity, diffusivity, and metabolism of the pyramidal tract adjacent to gliomas: a quantitative diffusion tensor fiber tracking and MR spectroscopic imaging study[J]. AJNR Am J Neuroradiol, 2007, 28 (3) : 462-469.
